{"id":"W1979836319","doi":"10.1158/0008-5472.sabcs-09-5111","title":"A Phase 1 Study To Assess the Safety, Tolerability and Pharmacokinetics of ARRY-380 – An Oral Inhibitor of HER2.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tolerability; Medicine; Pharmacokinetics; Dosing; Nausea; Rash; Adverse effect; Pharmacology; Internal medicine; Cancer; Toxicity; Pharmacodynamics; Breast cancer; Oncology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001859837,0.001481955,0.001705485,0.0003954234,0.0004551004,0.00071484,0.0009188111,0.001056537,0.004965839],"category_scores_gemma":[0.0009851856,0.0006798736,0.0007325906,0.0003365897,0.0008380561,0.001078237,0.000279445,0.003276635,0.001022822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00101008,"about_ca_system_score_gemma":0.001963254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008594082,"about_ca_topic_score_gemma":0.001590969,"domain_scores_codex":[0.999509,0.0002293119,0.00001755527,0.00009587628,0.0000702174,0.00007817303],"domain_scores_gemma":[0.9991927,0.0001447447,0.0001764747,0.00007908274,0.00006541239,0.0003415985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4737508,0.2244144,0.007924658,0.00123351,0.001417848,0.001062023,0.0005075996,0.0043106,0.1593138,0.0009961142,0.01461275,0.110456],"study_design_scores_gemma":[0.2649428,0.7092909,0.009253485,0.00003094834,0.0002701177,0.0009059314,0.00005927963,0.001812754,0.007482658,0.000485103,0.005427912,0.00003810118],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866791,0.001786934,0.001808886,0.0005333102,0.0001593713,0.004652916,0.001883884,0.0001198323,0.002375675],"genre_scores_gemma":[0.9731327,0.002157296,0.005258999,0.001463907,0.0002707488,0.005986951,0.005389821,0.00007033919,0.006269169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004965839,"threshold_uncertainty_score":0.01661241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2830463335743338,"score_gpt":0.5830860017591729,"score_spread":0.3000396681848391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}